Bristol Myers Squibb

Bristol-Myers Squibb (bmy) Q2 2021 earnings call transcript Nasdaq17:06
Bristol Myers hits CAR-T manufacturing bottleneck as Abecma demand outstrips supply FiercePharma15:54
Bristol Myers seeks redeeming combination for struggling checkpoint inhibitor BioSpace15:26
What to expect from Bristol Myers Squibb stock after Q2 results? Forbes14:02
Look out BMS, Cytokinetics has its eye on mavacamten’s turf pharmaphorum10:03
Bristol Myers Squibb's Opdivo and Yervoy combo falls short in first-line Scchc FiercePharma17:08

Latest News

Earlier today

BMS Sighs In Relief As Opdivo Returns To Sales Growth Scrip Pharma Intelligence00:01

Yesterday

Bristol-Myers Squibb (BMY) Q2 2021 Earnings Call Transcript Nasdaq17:06 28-Jul-21

Bristol Myers hits CAR-T manufacturing bottleneck as Abecma demand outstrips supply FiercePharma15:54 28-Jul-21

Bristol Myers Squibb Stock Rises After Modest Earnings Beat Barron's Online15:11 28-Jul-21

Bristol Myers Squibb (BMY) Q2 Earnings and Revenues Beat Estimates Nasdaq14:40 28-Jul-21

Bristol-Myers Squibb Reaffirms FY21 Adj. EPS Outlook - Quick Facts RTT News12:47 28-Jul-21

Bristol-Myers Squibb Earnings, Revenue Beat in Q2 Investing.com12:29 28-Jul-21

Acceleron Announces Second Quarter 2021 REBLOZYL® Net Sales Business Wire (Press Release)12:11 28-Jul-21

Bristol Myers Squibb Reports Second Quarter Financial Results for 2021 Business Wire (Press Release)12:03 28-Jul-21

In the last 7 days

Top Analyst Reports for Comcast, Coca-Cola & Bristol-Myers Squibb Nasdaq20:40 27-Jul-21

BMS, BridgeBio partner to study drug combo for lung cancer Outsourcing-Pharma.com16:03 27-Jul-21

Bristol Myers Seeks Redeeming Combination for Struggling Checkpoint Inhibitor BioSpace15:26 27-Jul-21

What To Expect From Bristol Myers Squibb Stock After Q2 Results? Forbes14:02 27-Jul-21

Bristol Myers Squibb catches the SHP2 wave in a new collaboration deal with BridgeBio ENDPOINTS12:35 27-Jul-21

Why It’s Hard to Go Wrong With Bristol Myers Stock Barron's Online11:07 27-Jul-21

BMS Withdraws Opdivo Liver Cancer Indication Following FDA Meeting BioSpace17:52 26-Jul-21

Hypertrophic Cardiomyopathy (HCM) Market Research Report 2021-2030: Major Players Include… PR Newswire (Press Release)15:54 26-Jul-21

BMS pulls speedy Opdivo approval for liver cancer in US pharmaphorum14:04 26-Jul-21

Bristol Myers, yielding to FDA pressure, pulls Opdivo in post-Nexavar liver cancer FiercePharma13:30 26-Jul-21

Bristol-Myers Squibb Company – Consensus Indicates Potential 10.9% Upside DirectorsTalk Interviews12:34 26-Jul-21

Another one bites the dust: Bristol Myers Squibb pulls 'dangling' accelerated approval for Opdivo in liver cancer ENDPOINTS12:19 26-Jul-21

Bristol-Myers Squibb’s Opdivo/Yervoy Combination Fails to Meet Endpoints in Head and Neck Cancer Trial Site News16:32 24-Jul-21

Bristol Myers Squibb: An Undervalued Dividend Stock With Growth Potential Seeking Alpha14:03 24-Jul-21

Bristol Myers Squibb Withdraws Single-Agent Nivolumab Post-Sorafenib HCC Indication in the United States OncLive11:12 24-Jul-21

In the last month

Look out BMS, Cytokinetics has its eye on mavacamten’s turf pharmaphorum10:03 20-Jul-21

Bristol-Myers Squibb Company – Consensus Indicates Potential 11.8% Upside DirectorsTalk Interviews14:22 19-Jul-21

Compugen Doses First Patient in Phase 1/2 Triple Combination Cohort Expansion of COM701 with Opdivo® and Bristol Myers… BioSpace12:26 19-Jul-21

Opdivo/Yervoy Combo Fails to Meet Endpoints in Head and Neck Cancer BioSpace17:17 16-Jul-21

Bristol Myers Squibb's Opdivo and Yervoy combo falls short in first-line SCCHC FiercePharma17:08 16-Jul-21

Bristol Myers Squibb takes another late-stage loss for Opdivo-Yervoy combo in head and neck cancer ENDPOINTS15:00 16-Jul-21

Bristol Myers Squibb Provides Update on CheckMate -651 Trial Evaluating Opdivo (nivolumab) Plus … Business Wire (Press Release)12:08 16-Jul-21

Bristol Myers Squibb (BMY) Dips More Than Broader Markets: What You Should Know Nasdaq00:24 16-Jul-21

Takeda, AbbVie, BMS, Sanofi, Lilly and others join growing tally of pharma's July price hikes:… FiercePharma17:13 15-Jul-21

Kentucky to share in $75 million settlement The Winchester Sun, Kentucky22:31 14-Jul-21

Personal Genome Diagnostics Appoints Mark Sausen as Vice President, Technology Innovation Business Wire (Press Release)14:04 13-Jul-21

Oncology Overview: Taking a Closer Look at Nivolumab Immunotherapy Pharmacy Times16:13 12-Jul-21

Bristol-Myers Squibb Company – Consensus Indicates Potential 13.0% Upside DirectorsTalk Interviews13:14 12-Jul-21

Can Gilead Beat Bristol Myers Squibb With Its Cancer CAR-T Therapy? The Motley Fool13:10 10-Jul-21

Bristol-Myers Squibb Is A High Yielding Blue-Chip That Should Appreciate Seeking Alpha21:42 9-Jul-21

NM AG's Suit Against Gilead, BMS Sent Back To State Court Law36023:16 7-Jul-21

BMS, GRYT Health collaborate on patient advocacy platform Outsourcing-Pharma.com17:03 6-Jul-21

Agenus says its Bristol Myers Squibb licensing deal has up to $1.3 billion in milestone payments MarketWatch14:27 6-Jul-21

EC green light for Opdivo plus Yervoy in metastatic colorectal cancer PharmaTimes05:12 1-Jul-21

3 Pharma Stocks with Tremendous Growth Potential Investing.com17:41 30-Jun-21

Keytruda beats Opdivo to first-line oesophageal cancer OK in Europe pharmaphorum13:31 30-Jun-21

EU approves BMS’s treatment for metastatic colorectal cancer Pharmafile09:58 30-Jun-21

Bristol Myers will likely settle the $6.4B Celgene CVR lawsuit at a discount, analyst says.… FiercePharma16:47 29-Jun-21

Bristol-Myers Squibb Co Ranked Among Today’s Top Buys Forbes15:31 29-Jun-21

Ex-Dividend Reminder: Sysco, Bristol Myers Squibb and Hannon Armstrong Sustainable Infrastructure Capital Nasdaq15:25 29-Jun-21

Global Induced Pluripotent Stem Cells Market Report 2021-2026: Leading Players are Applied… PR Newswire (Press Release)18:05 28-Jun-21

Gilead's Kite matches Bristol Myers with Yescarta CAR-T win in earlier lymphoma FiercePharma16:11 28-Jun-21

BMS’ CAR T therapy Abecma moves closer toward EU approval PharmaTimes07:25 28-Jun-21

view more headlines

29 Jul 00:01

Bristol Myers Squibb News

NewsNow brings you the latest news from the world’s most trusted sources on Bristol Myers Squibb. NewsNow aims to be the world’s most accurate and comprehensive Bristol Myers Squibb news aggregator, bringing you the latest headlines automatically and continuously 24/7. N.B. Relevance is automatically assessed so some headlines not qualifying as Bristol Myers Squibb news might appear - please feel free to contact us regarding any persistent issues.

Bristol Myers Squibb

Latest News

Bristol Myers Squibb News

Pharmaceuticals Top Stories

UK Top Stories

World Top Stories

NewsNow Classifieds Top Searches

NewsNow Classifieds

Top Searches